Table 5 Malaria treatment practices using Malact@ (Artesunate and Amodiquine)
Experimental group | Control group | |||||||
|---|---|---|---|---|---|---|---|---|
Pre-interventionn = 200 (%) | Post-interventionn = 190 (%) | Degree of change (%) | P value | Pre-interventionn = 200 (%) | Post-interventionn = 180 (%) | Degree of change (%) | P value | |
Malact@ efficacy | ||||||||
Efficient | 195 (97.5) | 190 (100.0) | 2.5 | 0.28 | 194 (97.0) | 176 (97.7) | −0.7 | 0.64 |
Not efficient | 5 (2.5) | 0 (0.0) | -2.5 | 6 (3.0) | 4 (2.3) | 0.7 | ||
Malact@ Dose | ||||||||
Correct | 36 [18.0] | 140 [73.7] | 55.7% | <0.001 | 45 [22.5] | 40 [22.2] | −0.3% | 0.78 |
Over dose | 92 [46.0] | 32 [16.8] | 29.2% | 86 [43.0] | 72 [40.0] | − 3.0% | ||
Under dose | 72 [36.0] | 18 [9.5] | 26.5% | 69 [34.5] | 68 [37.8] | 3.2% | ||
Treatment duration (days) | ||||||||
1 | 17 (8.5) | 0 (0.0) | −8.5 | <0.001 | 11 (5.5) | 10 (5.5) | 0.0 | 0.79 |
2 | 26 (13.0) | 27 (14.2) | 0.9 | 49 (24.5) | 46 (25.6) | 0.9 | ||
> 3 | 120 (60.0) | 159 (83.7) | 23.9 | 132 (66.0) | 113 (62.8) | -3.2 | ||
3 | 37 (18.5) | 4 (2.1) | -16.3 | 8 (4.0) | 11 (7.1) | 3.1 | ||
Commence treatment after symptom recognition | ||||||||
First day | 146 (73.0) | 185 (97.4) | 24.4 | <0.001 | 101 (50.5) | 88 (48.9) | −1.6 | 0.64 |
Second day | 47 (23.5) | 5 (2.6) | -20.9 | 72 (36.0) | 72 (40.0) | 4.4 | ||
Third day | 7 (3.5) | 0 (0.0) | -3.5 | 27 (13.5) | 20 (11.1) | -2.6 | ||